Related Experiment Videos
Coxsackie B virus antibodies in myocardial infarction
Insights
Coxsackie B virus infections may be linked to myocardial infarction. A study found significantly higher antibody increases against these viruses in heart attack patients compared to controls.
Area of Science:
- Cardiology
- Virology
- Epidemiology
Background:
- Myocardial infarction (MI) is a leading cause of mortality worldwide.
- The role of viral infections, particularly Coxsackie B virus (CBV), in the etiology of MI remains under investigation.
- Previous studies suggest a potential link, but conclusive evidence is limited.
Purpose of the Study:
- To investigate the association between Coxsackie B virus infections and acute myocardial infarction.
- To determine if elevated antibody titers against CBV are more prevalent in MI patients than in a healthy control group.
Main Methods:
- A prospective follow-up study design was employed.
- Micro neutralization tests were used to detect and quantify antibodies against Coxsackie B1-5 viruses in paired serum samples.
- Patients with acute myocardial infarction (n=59) and healthy controls (n=38) were recruited.
- Virus isolation attempts from throat and fecal samples were performed.
Main Results:
- A significantly higher proportion of myocardial infarction patients (15%, 9/59) exhibited a fourfold or greater increase in antibodies against Coxsackie B viruses compared to controls (2.6%, 1/38) (p ≤ 0.05).
- No patients or controls reported symptoms of viral infection during blood sampling.
- Virus isolation was negative in all participants, suggesting a past infection or immune response.
Conclusions:
- The findings support a potential causal or triggering role of Coxsackie B virus infections in the development of myocardial infarction.
- Further research is warranted to elucidate the precise mechanisms underlying this association.
- This study contributes to understanding the viral contribution to cardiovascular disease.
Abstract:
Evidence for the association between Coxsackie B virus infections and myocardial infarction was studied in a prospective follow-up examination. Using the micro neutralization test, 9 (15%) of 59 patients with acute myocardial infarction and 1 (2.6%) of 38 control patients showed a fourfold, or higher, antibody increase in paired serum samples against Coxsackie B1-5 viruses. This difference is significant (p less than or equal to 0.05). None of the patients or controls revealed symptoms of a viral infection during the blood sampling. Virus isolation from throat and feces was negative in all patients and controls. This finding agrees with some previous studies suggesting that the Coxsackie B group may in some cases have a causal role in myocardial infarction, or may act as a triggering factor.